日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Health Inequity of Stage and Survival of Gastric Cancer in California

加州胃癌分期和生存率方面的健康不平等

Ituarte, Philip H G; Sullivan, Kevin; Jankowska, Marta M; Nelson, Rebecca; Huang, Robert; Hernandez, Matthew C; Wong, Chi Wan; Deshpande, Supriya; Paz, I Benjamin; Melstrom, Laleh; Kim, Edward S; Fong, Yuman; Woo, Yanghee; On Behalf Of The Social Determinants Of Health Research Working Group

CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB-IIIA NSCLC

CANOPY-N:一项评估卡那单抗或帕博利珠单抗单药或联合用药作为新辅助治疗可切除的IB-IIIA期非小细胞肺癌患者的II期研究

Lee, Jay M; Pujol, Jean-Louis; Zhang, Jun; Leonov, Oleg; Tsuboi, Masahiro; Kim, Edward S; Ng, Calvin; Moreno-Mata, Nicolas; Cummings, Amy; Hacibekiroglu, Ilhan; Sehitogullari, Abidin; Veeramachaneni, Nirmal; Spillane, Cathy; Duan, Jiawei; Bossen, Claudia; Savchenko, Alexander; Lobetti-Bodoni, Chiara; Mok, Tony; Garrido, Pilar

Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials

伦理与临床研究:提高I期肿瘤临床试验的透明度和知情同意率

Frankel, Paul H; Groshen, Susan; Beumer, Jan H; Cleveland, Laura; Kim, Edward S; Karp, Judith E

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

去分化脂肪肉瘤患者的基因组改变和临床结局

Jagosky, Megan H; Anderson, Colin J; Symanowski, James T; Steuerwald, Nury M; Farhangfar, Carol J; Baldrige, Emily A; Benbow, Jennifer H; Livingston, Michael B; Patt, Joshua C; Ahrens, Will A; Kneisl, Jeffrey S; Kim, Edward S

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

基于血液的肿瘤突变负荷作为阿特珠单抗治疗非小细胞肺癌的生物标志物:B-F1RST II期试验

Kim, Edward S; Velcheti, Vamsidhar; Mekhail, Tarek; Yun, Cindy; Shagan, Sarah M; Hu, Sylvia; Chae, Young Kwang; Leal, Ticiana A; Dowell, Jonathan E; Tsai, Michaela L; Dakhil, Christopher S R; Stella, Philip; Jin, Yanling; Shames, David S; Schleifman, Erica; Fabrizio, David A; Phan, See; Socinski, Mark A

Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials

Brigatinib治疗克唑替尼耐药的ALK+非小细胞肺癌的长期疗效和安全性:1/2期和随机2期(ALTA)试验的最终结果

Gettinger, Scott N; Huber, Rudolf M; Kim, Dong-Wan; Bazhenova, Lyudmila; Hansen, Karin Holmskov; Tiseo, Marcello; Langer, Corey J; Paz-Ares Rodríguez, Luis G; West, Howard L; Reckamp, Karen L; Weiss, Glen J; Smit, Egbert F; Hochmair, Maximilian J; Kim, Sang-We; Ahn, Myung-Ju; Kim, Edward S; Groen, Harry J M; Pye, Joanna; Liu, Yuyin; Zhang, Pingkuan; Vranceanu, Florin; Camidge, D Ross

Phase 3 Trial of BI 695502 Plus Chemotherapy Versus Bevacizumab Reference Product Plus Chemotherapy in Patients With Advanced Nonsquamous NSCLC

BI 695502联合化疗与贝伐珠单抗参考产品联合化疗治疗晚期非鳞状非小细胞肺癌患者的III期临床试验

Kim, Edward S; Balser, Sigrid; Rohr, Klaus B; Lohmann, Ragna; Liedert, Bernd; Schliephake, Dorothee

Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

ON-TRK 研究的原理和设计:一项针对接受拉罗替尼治疗的 TRK 融合癌患者的新型前瞻性非干预性研究

Yang, James C H; Brose, Marcia S; Castro, Gilberto; Kim, Edward S; Lassen, Ulrik N; Leyvraz, Serge; Pappo, Alberto; López-Ríos, Fernando; Reeves, John A; Fellous, Marc; Penault-Llorca, Frédérique; Rudzinski, Erin R; Tabatabai, Ghazaleh; Vassal, Gilles; Drilon, Alexander; Trent, Jonathan

Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials

推进包容性研究:建立合作策略以提高临床试验的多样性

Garrick, Owen; Mesa, Ruben; Ferris, Andrea; Kim, Edward S; Mitchell, Edith; Brawley, Otis W; Carpten, John; Carter, Keith D; Coney, Joseph; Winn, Robert; Monroe, Stephanie; Sandoval, Fabian; Perez, Edith; Williams, Mitzi; Grove, Evan; Highsmith, Quita; Richie, Nicole; Begelman, Susan M; Collins, Asha S; Freedman, Jamie; Gonzales, Melissa S; Wilson, Gerren

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group

临床试验入组标准现代化:ASCO-癌症研究之友既往治疗工作组的建议

Osarogiagbon, Raymond U; Vega, Diana Merino; Fashoyin-Aje, Lola; Wedam, Suparna; Ison, Gwynn; Atienza, Sol; De Porre, Peter; Biswas, Tithi; Holloway, Jamie N; Hong, David S; Wempe, Madison M; Schilsky, Richard L; Kim, Edward S; Wade, James L 3rd